Nexlizet (bempedoic acid and ezetimibe), 180ng/18mg, 30 tablets, Rx only, Manufactured for: Esperion Therapeutics, Inc, Ann Arbor, MI 48108, NDC 72426-818-03

Recall Number: D-1143-2023

Firm: Esperion

Classification: Class III

Status: Terminated

Report Date: 20230913

Initiation Date: 20230816

Termination Date: 20260831

Reason for Recall

Failed dissolution specifications: below specification results at stability 12-month

Product Description

Nexlizet (bempedoic acid and ezetimibe), 180ng/18mg, 30 tablets, Rx only, Manufactured for: Esperion Therapeutics, Inc, Ann Arbor, MI 48108, NDC 72426-818-03